PMID- 35835295 OWN - NLM STAT- MEDLINE DCOM- 20220816 LR - 20220927 IS - 1878-5492 (Electronic) IS - 0966-3274 (Linking) VI - 74 DP - 2022 Oct TI - A clinical research of 11cases of human umbilical cord mesenchymal stem cells for curing senile vascular dementia. PG - 101669 LID - S0966-3274(22)00143-5 [pii] LID - 10.1016/j.trim.2022.101669 [doi] AB - BACKGROUND: Patients affected by senile vascular dementia (VaD) suffer from a gradual deterioration in their cognitive expressions as well as the ability of taking care for themselves. This study aimed to investigate the clinical efficacy and safety of improving cognitive function and daily life activities of patients with VaD by transplanting human umbilical cord mesenchymal stem cells (HUCMSCs). METHODS: A total number of 11 patients with senile VaD, who were admitted through outpatient treatment and hospitalized between February 2013 and February 2016, were selected. The diagnosis was based on CT and MRI examinations. The cultivated HUCMSCs (10(6) /kg) were injected by intravenous (i.v.) infusion on three occasions. Patients were evaluated for the Mini-Mental State Examination (MMSE) with 25-30 as normal, 21-24 as mild dementia, 10-20 as moderate dementia, and 0-9 as severe dementia. In addition, the Barthel index (BI) was used for a standardized activities of daily living (ADLs) with 0-20 as total dependence, 21-60 as severe dependence, 61-90 as moderate dependence, and 91-95 slight dependence. The t-test was performed to compare statistical significance. RESULTS: The study included 11 subjects, one of whom fell out due to an event unrelated to the study. The results show descriptive statistics at different time points. No matter MMSE score or Barthel index, the difference between before treatment and after treatment or follow-up was statistically significant (P < 0.001).Result interpretation: this intervention method has a significant therapeutic effect, and in the 3-month follow-up period, the intervention effect is still significant compared with that before treatment. CONCLUSIONS: Our preliminary clinical observations suggest that the i.v. infusion of HUCMSCs significantly improved the cognitive function (MMSE) and daily life activities (BI) of patients with senile VaD. This approach may prove to be safe and relatively simple method to be applied for the treatment of senile VaD. CI - Copyright (c) 2022. Published by Elsevier B.V. FAU - Master, You Li AU - Master YL AD - Department of Geriatric, The Second People's Hospital of Kunming, Kunming, Yunnan 650204, China. FAU - Wei-Meng Tian, Bachelor AU - Wei-Meng Tian B AD - Department of Geriatric, The Second People's Hospital of Kunming, Kunming, Yunnan 650204, China. Electronic address: wmt2053_drtian@163.com. FAU - Xing-Fang Jin, Master AU - Xing-Fang Jin M AD - Department of Geriatric, Yan'an Hospital of Kunming City, Kunming, Yunnan 650051, China. FAU - Zong-Liu Hou, Postgraduates AU - Zong-Liu Hou P AD - Department of Geriatric, Yan'an Hospital of Kunming City, Kunming, Yunnan 650051, China. FAU - Jing-Ping-Wang, Bachelor AU - Jing-Ping-Wang B AD - Department of Geriatric, The Second People's Hospital of Kunming, Kunming, Yunnan 650204, China. FAU - Yun-Shan Zhang, Bachelor AU - Yun-Shan Zhang B AD - Department of Geriatric, The Second People's Hospital of Kunming, Kunming, Yunnan 650204, China. FAU - Feng-Yun Luo, Bachelor AU - Feng-Yun Luo B AD - Department of Geriatric, The Second People's Hospital of Kunming, Kunming, Yunnan 650204, China. FAU - Jian-Pei Su, Master AU - Jian-Pei Su M AD - Department of Geriatric, The Second People's Hospital of Kunming, Kunming, Yunnan 650204, China. FAU - Jun Wang, Bachelor AU - Jun Wang B AD - Department of Geriatric, Yan'an Hospital of Kunming City, Kunming, Yunnan 650051, China. FAU - Ming-Hui Meng, Postgraduates AU - Ming-Hui Meng P AD - Department of Geriatric, Yan'an Hospital of Kunming City, Kunming, Yunnan 650051, China. FAU - Yan He, Postgraduates AU - Yan He P AD - Department of Geriatric, Yan'an Hospital of Kunming City, Kunming, Yunnan 650051, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220711 PL - Netherlands TA - Transpl Immunol JT - Transplant immunology JID - 9309923 SB - IM MH - Activities of Daily Living MH - *Alzheimer Disease/diagnosis/drug therapy MH - *Dementia/diagnosis/therapy MH - *Dementia, Vascular/diagnosis/drug therapy MH - Humans MH - *Mesenchymal Stem Cells MH - Umbilical Cord OTO - NOTNLM OT - Clinical research OT - Human umbilical cord mesenchymal stem cells OT - Senile vascular dementia EDAT- 2022/07/15 06:00 MHDA- 2022/08/17 06:00 CRDT- 2022/07/14 19:35 PHST- 2022/03/10 00:00 [received] PHST- 2022/07/08 00:00 [revised] PHST- 2022/07/08 00:00 [accepted] PHST- 2022/07/15 06:00 [pubmed] PHST- 2022/08/17 06:00 [medline] PHST- 2022/07/14 19:35 [entrez] AID - S0966-3274(22)00143-5 [pii] AID - 10.1016/j.trim.2022.101669 [doi] PST - ppublish SO - Transpl Immunol. 2022 Oct;74:101669. doi: 10.1016/j.trim.2022.101669. Epub 2022 Jul 11.